Agency Forms Undergoing Paperwork Reduction Act Review, 36556-36558 [2021-14751]

Download as PDF 36556 Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices characteristics, medical care, HIV testing, pre-exposure prophylaxis, antiretroviral treatment, sexually transmitted diseases (STD) history, symptoms of early HIV infection, substance use and sexual behavior. Data from the surveys will be merged with HIV test results and relevant clinical data using the unique identification (ID) number. Data will be stored on a secure server managed by the awardee’s Information Technology (IT) Services. The participation of respondents is voluntary. There is no cost to the respondents other than their time. The total estimated annual burden hours for the proposed project are 1,594 hours. become concordant (i.e., at the last Phase 2 visit) participants will complete the Phase 2 Behavioral Survey to identify any behavioral changes during follow-up. Of the 50 Phase 2 participants; it is estimated that no more than 26, annually, will have early HIV infection. All data for the proposed information collection will be collected via an electronic Computer Assisted SelfInterview (CASI) survey. Participants will complete the surveys on an encrypted computer, with the exception of the Phase 2 Symptom and Care survey, which will be administered by a research assistant and then electronically entered into the CASI system. Data to be collected via CASI include questions on sociodemographic (indicating one or more false-positive test results in Phase 1). The follow-up schedule will consist of up to nine visits scheduled at regular intervals over a 70-day period. At each follow-up visit, participants will be tested with the new HIV tests and additional oral fluid and blood specimens will also be collected for storage and use in future HIV test evaluations at CDC. Participants will be followed only to the point at which all their test results become concordant. At each time point, participants will be asked to complete the Phase 2 HIV Symptom and Care survey to collect information on symptoms associated with early HIV infection as well as access to HIV care and treatment since the last Phase 2 visit. When all tests ESTIMATED ANNUALIZED BURDEN HOURS Average burden per response (in hours) Total burden (in hours) Form name Persons eligible for study. Enrolled participants ...... Phase 1 Consent ................................................. 2,334 1 15/60 584 Phase Phase Phase Phase Enrollment Survey ................................. Consent ................................................. HIV Symptom and Care survey ............ Behavioral Survey ................................. 1,867 50 50 50 1 1 9 1 30/60 15/60 5/60 30/60 934 13 38 25 Total ........................ .............................................................................. ........................ ........................ ........................ 1,594 1 2 2 2 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2021–14754 Filed 7–9–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30 Day–21–1242] Agency Forms Undergoing Paperwork Reduction Act Review khammond on DSKJM1Z7X2PROD with NOTICES Number of responses per respondent Number of respondents Type of respondents In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Strengthening U.S. Response to Resistant Gonorrhea (SURRG) to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on September 30, 2020 to obtain comments from the public and affected agencies. VerDate Sep<11>2014 17:26 Jul 09, 2021 Jkt 253001 CDC received one non-substantive comment related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570. Comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/ do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Strengthening U.S. Response to Resistant Gonorrhea (SURRG) (OMB Control No. 0920–1242, Exp. 9/30/ 2021)—Revision—National Center for HIV/AIDS, Viral Hepatitis, STD, and TB E:\FR\FM\12JYN1.SGM 12JYN1 36557 Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). khammond on DSKJM1Z7X2PROD with NOTICES Background and Brief Description The purposes of Strengthening U.S. Response to Resistant Gonorrhea (SURRG) are to: (1) Improve national capacity to detect, monitor, and respond to the emerging threat of antibioticresistant gonorrhea, (2) understand trends in and factors contributing to antibiotic-resistant gonorrhea, and (3) build a robust evidence-base for public health action. This information collection is important because: (1) Effective treatment of gonorrhea is critical to gonorrhea control and prevention, (2) untreated or inadequately treated gonorrhea can cause serious reproductive health complications, such as infertility, (3) Neisseria gonorrhoeae (the bacterium that causes gonorrhea) has consistently demonstrated the ability to develop resistance to the antibiotics used for treatment and may be developing resistance to the last remaining treatment option recommended by the Centers for Disease Control and Prevention (CDC), and (4) antibioticresistant gonorrhea is extremely difficult to detect without enhanced surveillance and public health activities, such as SURRG, because healthcare providers rarely perform or have access to resistance testing for individual patients. SURRG supports rapid detection of resistant gonorrhea and gets actionable information into the hands of healthcare providers (to support appropriate treatment of individual patients) and local health departments (to support rapid public health response to slow the spread of resistant infections in the community). Jurisdictions participating in SURRG applied as part of a competitive process and participate voluntarily. As an overview of SURRG, healthcare providers at participating clinics (sexually transmitted disease [STD] clinics affiliated with a single public health department or other participating non-STD clinic sites) collect specimens for N. gonorrhoeae culture testing from men and women seeking care for possible gonorrhea. Specimens that demonstrate N. gonorrhoeae (called ‘‘isolates’’) undergo antibiotic resistance testing within several days at a local public health laboratory. Laboratory results demonstrating resistance are rapidly communicated by the laboratory staff to the healthcare provider and designated health department staff member, who initiates a field investigation. The patient (from whom the resistant specimen was collected) is interviewed about risk factors and recent contacts, and will be re-tested to ensure that they were cured. Recent contacts are interviewed by the health department (contact tracing) and tested for gonorrhea. The participating health departments collect and transmit to CDC demographic and clinical data about persons tested for, and diagnosed with gonorrhea in the participating clinics, results of local antibiotic resistance testing, and information about field investigations. None of the data transmitted to CDC contains any personally identifiable information. These data are used by CDC to monitor resistance, understand risk factors for resistance, and identify the most effective approaches to prevent the spread of resistance. Data are transmitted through CDC’s Secure Access Management Services (SAMS). SAMS is an approved federal information technology system that provides authorized and validated users secure and encrypted access to CDC file transfer applications. The encrypted data are stored in a secure CDC server with strictly controlled and restricted access rights. Isolates are shipped each month to one of four Antibiotic Resistance Regional Laboratory Network (ARLN) laboratories for confirmatory antibiotic susceptibility testing and molecular characterization. The isolates only contain bacterial DNA (and not human DNA). Under the SURRG protocol, the local SURRG data managers from each of the funded jurisdictions abstract STD clinic data for patients tested for gonorrhea, receive data from non-STD clinic healthcare sites about persons tested for gonorrhea, receive resistance testing laboratory results from local public health laboratories, abstract data about field investigations, and merge the data. Every two months, the local SURRG data manager cleans the data, removes personally identifiable information, and transmits the data to CDC. We estimate these data processes will take 16 hours every two months. Annually, the local SURRG data manager will send a final cumulative data file, so a total of seven data transmissions/responses will occur. Every two months, data managers at each of the participating non-STD clinic health centers abstract and clean data and securely transmits the data to the local SURRG data manager. We estimate that it will take three hours each time data managers at each non-STD SURRG location abstract, clean, and transmit SURRG data. Microbiologists at public health laboratories from each of the eight SURRG funded jurisdictions conduct antibiotic resistance testing on all N. gonorrhoeae isolates from all STD clinic sites and non-STD clinic sites participating in SURRG. Each test takes approximately 10 minutes of staff time, and testing of control strains is also conducted approximately twice per week at each laboratory. On average, each jurisdiction conducts approximately 600 resistance tests per year for patient care, plus 100 control strains per year for quality assurance. Thus, a total of approximately 700 tests per year per grantee are performed. Every two months, a laboratory data manager abstracts test results and securely sends the datafile to the local SURRG data manager. We estimate that laboratory data managers spend approximately one hour each time they abstract, clean, and transmit project data. Health department staff will interview: Any person diagnosed with antibiotic-resistant gonorrhea or have a case of gonorrhea of public health significance index case, and their sexual contacts. On average, each jurisdiction will identify four drug-resistant isolates each month. These isolates will spur field investigations, which will result in six additional interviews each month. We estimate a total of 120 interviews will occur annually at each site, for a total across the 8 sites of 960 interviews each year. Each interview will take approximately 20 minutes. The total estimated annual burden hours are 2,665. There are no additional costs to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Form name Local SURRG data manager .......................... Facility Data Elements ................................... VerDate Sep<11>2014 17:26 Jul 09, 2021 Jkt 253001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 Number of responses per respondent Number of respondents Type of respondents E:\FR\FM\12JYN1.SGM 8 12JYN1 7 Average burden per response (in hours) 16 36558 Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of responses per respondent Average burden per response (in hours) Form name Data manager at non-STD clinic health centers. Public Health Laboratory Microbiologist ......... Public Health Laboratory Data Manager ........ Gonorrhea Patients and Sexual Contacts ...... Non-STD clinic Data Elements ...................... 26 6 3 Laboratory Testing Data Elements ................ Laboratory Data Elements ............................. Field Investigation Data Elements ................. 8 8 960 700 6 1 10/60 1 20/60 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. Stephen Antkowiak, Office of Refugee Resettlement, Division of Unaccompanied Alien Children Operations, 330 Street SW, Washington, DC 20447. Phone: 202–260–6165. Email: stephen.antkowiak@acf.hhs.gov. BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Announcement of Intent To Issue One Operating Division (OPDIV)-Initiated Supplement to BCFS Health and Human Services Under the Standing Announcement for Residential (Shelter) Services for Unaccompanied Alien Children, HHS–2017–ACF–ORR– ZU–1132 Unaccompanied Alien Children’s (UAC) Program, Office of Refugee Resettlement (ORR), Administration for Children and Families (ACF), Department of Health and Human Services (HHS). AGENCY: Notice of intent to issue one OPDIV-Initiated Supplement to BCFS Health and Human Services (BCFS HHS), San Antonio, Texas under the UAC Program. ACTION: ACF, ORR, announces the issuance of one OPDIV-Initiated Supplement to BCFS HHS, San Antonio, Texas in the amount of up to $475,868,102. ORR has been identifying additional capacity to provide shelter for potential increases in apprehensions of UAC at the Southwest Border. Planning for increased shelter capacity is a prudent step to ensure that ORR is able to meet its responsibility, by law, to provide shelter for UAC referred to its care by the Department of Homeland Security. To ensure sufficient capacity to provide shelter to UAC referred to HHS, ORR is requesting that BCFS HHS continue the use of up to 1008 hardsided beds at Carrizo Springs, Texas. VerDate Sep<11>2014 17:26 Jul 09, 2021 Jkt 253001 ORR is continuously monitoring its capacity to shelter the UAC referred to HHS, as well as the information received from interagency partners, to inform any future decisions or actions. ORR has specific requirements for the provision of services. Award recipients must have the infrastructure, licensing, experience, and appropriate level of trained staff to meet those requirements. The expansion of the existing program and its services through this supplemental award is a key strategy for ORR to be prepared to meet its responsibility to provide shelter for UAC referred to its care by the Department of Homeland Security (DHS), and so the Customs and Border Protection can continue its vital national security mission to prevent illegal migration, trafficking, and protect the borders of the United States. Statutory Authority: This program is authorized by— (A) Section 462 of the Homeland Security Act of 2002, which in March 2003, transferred responsibility for the care and custody of UAC from the Commissioner of the former Immigration and Naturalization Service to the Director of ORR within HHS. (B) The Flores Settlement Agreement, Case No. CV85–4544–RJK (C.D. Cal. 1996), as well as the William Wilberforce Trafficking Victims Protection Reauthorization Act of 2008 (Pub. L. 110–457), which authorizes post release services under certain conditions to eligible children. All programs must comply with the Flores Settlement Agreement, Case No. CV85– 4544–RJK (C.D. Cal. 1996); pertinent SUPPLEMENTARY INFORMATION: [CFDA Number: 93.676] SUMMARY: Supplemental award funds will support activities until January 31, 2022. DATES: FOR FURTHER INFORMATION CONTACT: [FR Doc. 2021–14751 Filed 7–9–21; 8:45 am] khammond on DSKJM1Z7X2PROD with NOTICES Number of respondents Type of respondents PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 regulations; and ORR policies and procedures. Elizabeth Leo, Senior Grants Policy Specialist, Office of Grants Policy, Office of Administration. [FR Doc. 2021–14722 Filed 7–7–21; 4:15 pm] BILLING CODE 4184–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Community Living [OMB# 0985–New] Agency Information Collection Activities; Proposed Collection; Comment Request; Evidence Based Program Fidelity Surveys Administration for Community Living, HHS. ACTION: Notice. AGENCY: The Administration for Community Living (ACL) is announcing an opportunity for the public to comment on the proposed collection of information listed above. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish a notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection requirements relating to a Grantee Survey and a Local Implementation Organization Survey that will be used by ACL to evaluate the fidelity with which ACL and its grantee organizations, under the Older Americans Act, implement the required evidence-based programs. DATES: Comments on the collection of information must be submitted electronically by 11:59 p.m. (EST) or postmarked by September 10, 2021. ADDRESSES: Submit electronic comments on the collection of information to: Susan.Jenkins@ acl.hhs.gov. Submit written comments on the collection of information to SUMMARY: E:\FR\FM\12JYN1.SGM 12JYN1

Agencies

[Federal Register Volume 86, Number 130 (Monday, July 12, 2021)]
[Notices]
[Pages 36556-36558]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14751]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 Day-21-1242]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Strengthening U.S. Response to Resistant 
Gonorrhea (SURRG) to the Office of Management and Budget (OMB) for 
review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
September 30, 2020 to obtain comments from the public and affected 
agencies. CDC received one non-substantive comment related to the 
previous notice. This notice serves to allow an additional 30 days for 
public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Strengthening U.S. Response to Resistant Gonorrhea (SURRG) (OMB 
Control No. 0920-1242, Exp. 9/30/2021)--Revision--National Center for 
HIV/AIDS, Viral Hepatitis, STD, and TB

[[Page 36557]]

Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The purposes of Strengthening U.S. Response to Resistant Gonorrhea 
(SURRG) are to: (1) Improve national capacity to detect, monitor, and 
respond to the emerging threat of antibiotic-resistant gonorrhea, (2) 
understand trends in and factors contributing to antibiotic-resistant 
gonorrhea, and (3) build a robust evidence-base for public health 
action. This information collection is important because: (1) Effective 
treatment of gonorrhea is critical to gonorrhea control and prevention, 
(2) untreated or inadequately treated gonorrhea can cause serious 
reproductive health complications, such as infertility, (3) Neisseria 
gonorrhoeae (the bacterium that causes gonorrhea) has consistently 
demonstrated the ability to develop resistance to the antibiotics used 
for treatment and may be developing resistance to the last remaining 
treatment option recommended by the Centers for Disease Control and 
Prevention (CDC), and (4) antibiotic-resistant gonorrhea is extremely 
difficult to detect without enhanced surveillance and public health 
activities, such as SURRG, because healthcare providers rarely perform 
or have access to resistance testing for individual patients.
    SURRG supports rapid detection of resistant gonorrhea and gets 
actionable information into the hands of healthcare providers (to 
support appropriate treatment of individual patients) and local health 
departments (to support rapid public health response to slow the spread 
of resistant infections in the community). Jurisdictions participating 
in SURRG applied as part of a competitive process and participate 
voluntarily. As an overview of SURRG, healthcare providers at 
participating clinics (sexually transmitted disease [STD] clinics 
affiliated with a single public health department or other 
participating non-STD clinic sites) collect specimens for N. 
gonorrhoeae culture testing from men and women seeking care for 
possible gonorrhea. Specimens that demonstrate N. gonorrhoeae (called 
``isolates'') undergo antibiotic resistance testing within several days 
at a local public health laboratory. Laboratory results demonstrating 
resistance are rapidly communicated by the laboratory staff to the 
healthcare provider and designated health department staff member, who 
initiates a field investigation. The patient (from whom the resistant 
specimen was collected) is interviewed about risk factors and recent 
contacts, and will be re-tested to ensure that they were cured. Recent 
contacts are interviewed by the health department (contact tracing) and 
tested for gonorrhea. The participating health departments collect and 
transmit to CDC demographic and clinical data about persons tested for, 
and diagnosed with gonorrhea in the participating clinics, results of 
local antibiotic resistance testing, and information about field 
investigations. None of the data transmitted to CDC contains any 
personally identifiable information.
    These data are used by CDC to monitor resistance, understand risk 
factors for resistance, and identify the most effective approaches to 
prevent the spread of resistance. Data are transmitted through CDC's 
Secure Access Management Services (SAMS). SAMS is an approved federal 
information technology system that provides authorized and validated 
users secure and encrypted access to CDC file transfer applications. 
The encrypted data are stored in a secure CDC server with strictly 
controlled and restricted access rights. Isolates are shipped each 
month to one of four Antibiotic Resistance Regional Laboratory Network 
(ARLN) laboratories for confirmatory antibiotic susceptibility testing 
and molecular characterization. The isolates only contain bacterial DNA 
(and not human DNA).
    Under the SURRG protocol, the local SURRG data managers from each 
of the funded jurisdictions abstract STD clinic data for patients 
tested for gonorrhea, receive data from non-STD clinic healthcare sites 
about persons tested for gonorrhea, receive resistance testing 
laboratory results from local public health laboratories, abstract data 
about field investigations, and merge the data. Every two months, the 
local SURRG data manager cleans the data, removes personally 
identifiable information, and transmits the data to CDC. We estimate 
these data processes will take 16 hours every two months. Annually, the 
local SURRG data manager will send a final cumulative data file, so a 
total of seven data transmissions/responses will occur. Every two 
months, data managers at each of the participating non-STD clinic 
health centers abstract and clean data and securely transmits the data 
to the local SURRG data manager. We estimate that it will take three 
hours each time data managers at each non-STD SURRG location abstract, 
clean, and transmit SURRG data.
    Microbiologists at public health laboratories from each of the 
eight SURRG funded jurisdictions conduct antibiotic resistance testing 
on all N. gonorrhoeae isolates from all STD clinic sites and non-STD 
clinic sites participating in SURRG. Each test takes approximately 10 
minutes of staff time, and testing of control strains is also conducted 
approximately twice per week at each laboratory. On average, each 
jurisdiction conducts approximately 600 resistance tests per year for 
patient care, plus 100 control strains per year for quality assurance. 
Thus, a total of approximately 700 tests per year per grantee are 
performed. Every two months, a laboratory data manager abstracts test 
results and securely sends the datafile to the local SURRG data 
manager. We estimate that laboratory data managers spend approximately 
one hour each time they abstract, clean, and transmit project data.
    Health department staff will interview: Any person diagnosed with 
antibiotic-resistant gonorrhea or have a case of gonorrhea of public 
health significance index case, and their sexual contacts. On average, 
each jurisdiction will identify four drug-resistant isolates each 
month. These isolates will spur field investigations, which will result 
in six additional interviews each month. We estimate a total of 120 
interviews will occur annually at each site, for a total across the 8 
sites of 960 interviews each year. Each interview will take 
approximately 20 minutes.
    The total estimated annual burden hours are 2,665. There are no 
additional costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Local SURRG data manager..............  Facility Data Elements..               8               7              16

[[Page 36558]]

 
Data manager at non-STD clinic health   Non-STD clinic Data                   26               6               3
 centers.                                Elements.
Public Health Laboratory                Laboratory Testing Data                8             700           10/60
 Microbiologist.                         Elements.
Public Health Laboratory Data Manager.  Laboratory Data Elements               8               6               1
Gonorrhea Patients and Sexual Contacts  Field Investigation Data             960               1           20/60
                                         Elements.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-14751 Filed 7-9-21; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.